Managed Healthcare Executive January 23, 2021
Centralized technology that connects payers, providers and patients are needed to optimize telemedicine reimbursement, argues J.P. Morgan’s Kerry Jessani.
The rapid onset of COVID-19 forced many healthcare organizations to implement virtual care essentially overnight. Nearly one year later, the benefits of telemedicine have continued to become increasingly clear to both patients and organizations. It has the potential to expand communities’ access to specialized care, enable higher connectivity for at-risk patients and offer greater independence for individuals facing health challenges that require frequent monitoring.
While restrictions around payer reimbursements were previously a barrier to entry for some healthcare organizations, key policies have been temporarily amended to meet the increased need for virtual care during the pandemic. But as telemedicine continues...
Today's Sponsors
Today's Sponsor